Rehmannioside A alleviates renal inflammation and fibrosis in hypertensive nephropathy via AT1R/MAPK14/IL-17 signaling pathway
Authors:
- 19 June 2025
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 776, 152237
Abstract
No abstract availableKeywords
This publication has 53 references indexed in Scilit:
- α‐Mangostin Attenuates Blood Pressure and Reverses Vascular Remodeling by Balancing ACE/AT1R and ACE2/Ang‐(1–7)/MasR Axes in Ang II‐Infused Hypertensive MicePhytotherapy Research, 2024
- Selenium deficiency causes hypertension by increasing renal AT1 receptor expression via GPx1/H2O2/NF-κB pathwayFree Radical Biology and Medicine, 2023
- Clitoria ternatea (Linn.) flower extract attenuates vascular dysfunction and cardiac hypertrophy via modulation of Ang II/AT1R/TGF‐β1 cascade in hypertensive ratsJournal of the Science of Food and Agriculture, 2021
- Myeloid PTEN deficiency aggravates renal inflammation and fibrosis in angiotensin II‐induced hypertensionJournal of Cellular Physiology, 2021
- Inflammation in Salt-Sensitive Hypertension and Renal DamageCurrent Hypertension Reports, 2018
- Oridonin protects against the inflammatory response in diabetic nephropathy by inhibiting the TLR4/p38-MAPK and TLR4/NF-κB signaling pathwaysInternational Immunopharmacology, 2018
- Rehmanniae Radix in osteoporosis: A review of traditional Chinese medicinal uses, phytochemistry, pharmacokinetics and pharmacologyJournal of Ethnopharmacology, 2017
- The anti-inflammation effect of baicalin on experimental colitis through inhibiting TLR4/NF-κB pathway activationInternational Immunopharmacology, 2014
- Signaling of interleukin-17 family cytokines in immunity and inflammationCellular Signalling, 2011
- Intrarenal angiotensin II and its contribution to the genesis of chronic hypertensionCurrent Opinion in Pharmacology, 2011